Cubist Systematic Strategies, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,702,840
-50.2%
23,149
-54.7%
0.01%
-50.0%
Q4 2022$3,417,087
+300.1%
51,154
+415.6%
0.02%
+300.0%
Q3 2022$854,000
-46.2%
9,922
-44.2%
0.01%
-50.0%
Q2 2022$1,586,000
+13.3%
17,777
+42.8%
0.01%
-16.7%
Q1 2022$1,400,000
+191.1%
12,447
+299.5%
0.01%
+140.0%
Q4 2021$481,000
+64.2%
3,116
+48.0%
0.01%
+25.0%
Q3 2021$293,000
-61.6%
2,106
-63.8%
0.00%
-55.6%
Q2 2021$763,000
-74.1%
5,814
-70.0%
0.01%
-76.3%
Q1 2021$2,950,000
+18.3%
19,349
-22.8%
0.04%
+11.8%
Q4 2020$2,493,000
+242.0%
25,068
+227.7%
0.03%
+209.1%
Q3 2020$729,000
-50.3%
7,649
-41.6%
0.01%
-56.0%
Q2 2020$1,466,000
-21.4%
13,103
-48.9%
0.02%
-50.0%
Q1 2020$1,864,000
+728.4%
25,630
+1089.3%
0.05%
+1150.0%
Q4 2019$225,000
-95.3%
2,155
-95.5%
0.00%
-95.7%
Q3 2019$4,753,000
+49.8%
47,748
+71.8%
0.09%
+62.1%
Q2 2019$3,173,000
+21.4%
27,798
+33.7%
0.06%
-31.8%
Q1 2019$2,614,000
+153.3%
20,796
+173.5%
0.08%
+73.5%
Q4 2018$1,032,000
+172.3%
7,603
+103.9%
0.05%
+63.3%
Q4 2016$379,000
+10.8%
3,728
+30.1%
0.03%
+50.0%
Q2 2016$342,000
-5.8%
2,865
-14.5%
0.02%
-4.8%
Q4 2015$363,0000.0%3,349
-28.8%
0.02%
+16.7%
Q1 2015$363,000
+45.2%
4,703
+0.1%
0.02%
+38.5%
Q4 2014$250,000
+2.9%
4,700
-9.2%
0.01%
-13.3%
Q3 2014$243,0005,1760.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
VILLERE ST DENIS J & CO LLC 518,988$80,162,0004.60%
Knott David M Jr 75,000$11,585,0003.93%
Orchard Capital Management, LLC 68,596$10,595,0003.11%
Chicago Capital, LLC 436,456$67,415,0002.51%
RICE HALL JAMES & ASSOCIATES, LLC 347,699$53,706,0001.91%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 85,990$13,282,0001.46%
Smith, Graham & Co., Investment Advisors, LP 87,392$13,499,0001.34%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 44,754$6,913,0001.12%
WOODSTOCK CORP 68,666$10,606,0001.11%
Stephens Investment Management Group LLC 411,359$63,539,0000.82%
View complete list of LIGAND PHARMACEUTICALS INC shareholders